The Impact of 'A Miss Is as Good as a Mile': Is Compensation Necessary for Minimal Ocular Deviation in Myopic Laser Surgery?
Key facts
- Who runs it
- Zhongshan Ophthalmic Center, Sun Yat-sen University
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 224 people, planned
- Started
- 8 Apr 2026
- Expected to end
- 30 May 2027
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Apply compensation to the Kappa angle.
- Apply no compensation to the Kappa angle
- Record updated
- 7 July 2026
Who can take part
- Age
- 18 years to 40 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Patients aged 18 to 40 years with myopia or myopic astigmatism and stable refraction for >=1 year, whose refractive errors fall within the treatable range of and meet the indications for SMILE surgery
- Normal corneal morphology and corneal thickness meeting surgical requirements
- Preoperative corrected distance visual acuity (CDVA) >= 1.0
- Preoperative synthetic Kappa angle offset measured >= 0.10 mm and < 0.20 mm
- Voluntarily agree to undergo SMILE surgery on the VISUMAX 800 platform, understand the randomization scheme, and provide signed informed consent
Who cannot take part
- History of prior ocular surgery, significant ocular trauma, or presence of corneal or ocular diseases that may affect the safety of refractive surgery
- Severe systemic diseases that may affect ocular healing or surgical safety
- Females who are pregnant or lactating
- Inability to cooperate as required to complete the procedure or follow-up visits
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 18 and 40 years old?
This trial is currently available in China.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this clinical trial is to evaluate the effect of intraoperative kappa-angle compensation on postoperative visual quality in patients undergoing small incision lenticule extraction (SMILE) using the VisuMax 800 platform. The study will enroll patients with myopia and a kappa-angle offset < 0.2 mm.
Read full original descriptionShow less
The main questions it aims to answer are:
Does intraoperative kappa-angle compensation reduce postoperative higher-order aberrations after SMILE? Does kappa-angle compensation improve postoperative visual quality and refractive outcomes compared with no compensation?
Researchers will compare SMILE with intraoperative kappa-angle compensation to SMILE without compensation to determine whether compensation leads to better optical quality and visual performance.
Participants will:
Undergo SMILE surgery with or without intraoperative kappa-angle compensation Complete scheduled postoperative examinations at 1 week, 1 month, 3 months, and 6 months after surgery Receive measurements of visual acuity, refraction, higher-order aberrations, contrast sensitivity, and safety outcomes
The 2 groups in the trial
- Non-compensation groupExisting treatment, for comparison
Subjects underwent SMILE surgery on the VisuMax 800 platform. Preoperative offset coordinates (x, y) were measured; however, while preserving the directional sign, no kappa-angle-based laser centration compensation was applied intraoperatively, and the treatment center was set according to the system's default centration method. Except for the difference in compensation strategy, all other surgical procedures and postoperative management were identical to those in the compensation group.
Treatment: Apply no compensation to the Kappa angle
- Compensation groupTreatment being tested
Subjects underwent SMILE surgery on the VisuMax 800 platform. Preoperative offset coordinates (x, y) were measured, and, while preserving the directional sign, a fixed intraoperative laser centration compensation of 0.1 mm was uniformly applied to all eligible study eyes to achieve a quantitative adjustment of the treatment center toward the visual axis. Except for the difference in compensation strategy, all other surgical procedures and postoperative management were identical to those in the non-compensation group.
Treatment: Apply compensation to the Kappa angle.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Effect of Centration Compensation on Visual Quality in VisuMax 800 SMILE for Small Kappa Angles: A Randomized Trial
- Criteria questions
- Built from NCT07512115, who can take part
- Record updated
- 7 July 2026